Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Katherine R. Mariner"'
Autor:
Katherine R. Mariner, Ian Chopra, Janez Konc, Alex J. O'Neill, Blaž Vehar, Martina Hrast, Stanislav Gobec, Andreja Kovač, Dušanka Janežič
Publikováno v:
Bioorganic & Medicinal Chemistry. 19:5137-5146
d -Alanine: d -alanine ligase (Ddl), an intracellular bacterial enzyme essential for cell wall biosynthesis, is an attractive target for development of novel antimicrobial drugs. This study focused on an extensive evaluation of two families of Ddl in
Autor:
Katherine R. Mariner, Rachel Trowbridge, Colin W. G. Fishwick, Alex J. O'Neill, Ian Chopra, Martin J. McPhillie, A. Peter Johnson
Publikováno v:
ACS Medicinal Chemistry Letters. 2:729-734
Bacterial RNA polymerase (RNAP) is essential for transcription and is an antibacterial target for small molecule inhibitors. The binding region of myxopyronin B (MyxB), a bacterial RNAP inhibitor, offers the possibility of new inhibitor design. The m
Autor:
Martin J. McPhillie, Katherine R. Mariner, Rachel Trowbridge, Catriona Smith, Alex J. O'Neill, Ian Chopra, Colin W. G. Fishwick
Publikováno v:
Antimicrobial Agents and Chemotherapy. 55:2413-2416
We explored the properties of corallopyronin A (CorA), a poorly characterized inhibitor of bacterial RNA polymerase (RNAP). It displayed a 50% inhibitory concentration of 0.73 μM against RNAP, compared with 11.5 nM for rifampin. The antibacterial ac
Autor:
Martine Nguyen-Distèche, Nick K. Olrichs, Ana Maria Amoroso, Samo Turk, Jean-Marie Frère, Bernard Joris, Julieanne M. Bostock, Ian Chopra, Julien Offant, Katherine R. Mariner, Eefjan Breukink, Stanislav Gobec, Thierry Vernet, Adeline Derouaux, Mohammed Terrak, Astrid Zervosen
Publikováno v:
Biochemical Pharmacology
Biochemical Pharmacology, Elsevier, 2011, 81 (9), pp.1098. ⟨10.1016/j.bcp.2011.02.008⟩
Biochemical Pharmacology, Elsevier, 2011, 81 (9), pp.1098. ⟨10.1016/j.bcp.2011.02.008⟩
International audience; Bacterial peptidoglycan glycosyltransferases (GTs) of family 51 catalyze the polymerization of the lipid II precursor into linear peptidoglycan strands. This activity is essential to bacteria and represents a validated target
Autor:
Ian Chopra, Colin W. G. Fishwick, Katherine R. Mariner, Rachel Trowbridge, Keith W. Miller, Alex J. O'Neill, Anil Agarwal
Publikováno v:
Antimicrobial Agents and Chemotherapy. 54:4506-4509
Previous studies suggest that furanyl-rhodanines might specifically inhibit bacterial RNA polymerase (RNAP). We further explored three compounds from this class. Although they inhibited RNAP, each compound also inhibited malate dehydrogenase and chym
Publikováno v:
Antimicrobial Agents and Chemotherapy. 57:637-639
Antistaphylococcal agents commonly lack activity against Gram-negative bacteria like Escherichia coli owing to the permeability barrier presented by the outer membrane and/or the action of efflux transporters. When these intrinsic resistance mechanis
Publikováno v:
Antimicrobial Agents and Chemotherapy. 55:1784-1786
We further examined the usefulness of previously reported Bacillus subtilis biosensors for antibacterial mode-of-action studies. The biosensors could not detect the tRNA synthetase inhibitors mupirocin, indolmycin, and borrelidin, some inhibitors of